156 related articles for article (PubMed ID: 9932968)
1. A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration.
Higgins JJ; Litvan I; Nee LE; Loveless JM
Neurology; 1999 Jan; 52(2):404-6. PubMed ID: 9932968
[TBL] [Abstract][Full Text] [Related]
2. Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.
Gentry EG; Henderson BW; Arrant AE; Gearing M; Feng Y; Riddle NC; Herskowitz JH
J Neurosci; 2016 Jan; 36(4):1316-23. PubMed ID: 26818518
[TBL] [Abstract][Full Text] [Related]
3. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene.
Higgins JJ; Litvan I; Pho LT; Li W; Nee LE
Neurology; 1998 Jan; 50(1):270-3. PubMed ID: 9443491
[TBL] [Abstract][Full Text] [Related]
4. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Kertesz A; Munoz D
Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the tau gene in progressive supranuclear palsy.
Higgins JJ; Adler RL; Loveless JM
Neurology; 1999 Oct; 53(7):1421-4. PubMed ID: 10534245
[TBL] [Abstract][Full Text] [Related]
6. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
7. The tau gene A0 allele and progressive supranuclear palsy.
Hoenicka J; Pérez M; Pérez-Tur J; Barabash A; Godoy M; Vidal L; Astarloa R; Avila J; Nygaard T; de Yébenes JG
Neurology; 1999 Oct; 53(6):1219-25. PubMed ID: 10522876
[TBL] [Abstract][Full Text] [Related]
8. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy.
Di Maria E; Tabaton M; Vigo T; Abbruzzese G; Bellone E; Donati C; Frasson E; Marchese R; Montagna P; Munoz DG; Pramstaller PP; Zanusso G; Ajmar F; Mandich P
Ann Neurol; 2000 Mar; 47(3):374-7. PubMed ID: 10716259
[TBL] [Abstract][Full Text] [Related]
9. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.
Stanford PM; Halliday GM; Brooks WS; Kwok JB; Storey CE; Creasey H; Morris JG; Fulham MJ; Schofield PR
Brain; 2000 May; 123 ( Pt 5)():880-93. PubMed ID: 10775534
[TBL] [Abstract][Full Text] [Related]
10. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration.
Ishizawa K; Dickson DW
J Neuropathol Exp Neurol; 2001 Jun; 60(6):647-57. PubMed ID: 11398841
[TBL] [Abstract][Full Text] [Related]
11. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.
Morris HR; Janssen JC; Bandmann O; Daniel SE; Rossor MN; Lees AJ; Wood NW
J Neurol Neurosurg Psychiatry; 1999 May; 66(5):665-7. PubMed ID: 10209184
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic aspects of progressive supranuclear palsy.
Litvan I; Hutton M
J Geriatr Psychiatry Neurol; 1998; 11(2):107-14. PubMed ID: 9877531
[TBL] [Abstract][Full Text] [Related]
13. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.
Stamelou M; Quinn NP; Bhatia KP
Mov Disord; 2013 Aug; 28(9):1184-99. PubMed ID: 23720239
[TBL] [Abstract][Full Text] [Related]
14. Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.
Sanchez-Contreras M; Heckman MG; Tacik P; Diehl N; Brown PH; Soto-Ortolaza AI; Christopher EA; Walton RL; Ross OA; Golbe LI; Graff-Radford N; Wszolek ZK; Dickson DW; Rademakers R
Mov Disord; 2017 Jan; 32(1):115-123. PubMed ID: 27709685
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
[TBL] [Abstract][Full Text] [Related]
16. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
[TBL] [Abstract][Full Text] [Related]
17. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic variation of autosomal-dominant corticobasal degeneration.
Jung HH; Bremer J; Streffer J; Virdee K; Spillantini MG; Crowther RA; Brugger P; Van Broeckhoven C; Aguzzi A; Tolnay M
Eur Neurol; 2012; 67(3):142-50. PubMed ID: 22261560
[TBL] [Abstract][Full Text] [Related]
19. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP.
Jiang S; Wen N; Li Z; Dube U; Del Aguila J; Budde J; Martinez R; Hsu S; Fernandez MV; Cairns NJ; ; ; Harari O; Cruchaga C; Karch CM
Transl Psychiatry; 2018 Dec; 8(1):265. PubMed ID: 30546007
[TBL] [Abstract][Full Text] [Related]
20. 5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.
Cruchaga C; Vidal-Taboada JM; Ezquerra M; Lorenzo E; Martinez-Lage P; Blazquez M; Tolosa E; ; Pastor P
Neurobiol Dis; 2009 Feb; 33(2):164-70. PubMed ID: 19022385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
